Overview
Ozempic Pen 0.5 mg contains Semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist used for type 2 diabetes mellitus management. It is a once-weekly injectable medication that enhances glucose-dependent insulin secretion, reduces glucagon levels, slows gastric emptying, and promotes satiety. Ozempic helps improve blood sugar control and supports cardiovascular and weight management goals in adult patients.





